Cargando…
Microspheres for Drug Delivery
With advances in biotechnology, genomics, and combinatorial chemistry, a wide variety of new, more potent and specific therapeutics are being created. Because of common problems such as low solubility, high potency, and/or poor stability of many of these new drugs, the means of drug delivery can imp...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122341/ http://dx.doi.org/10.1007/978-0-387-25842-3_2 |
_version_ | 1783515397414191104 |
---|---|
author | Kim, Kyekyoon Kevin Pack, Daniel W. |
author_facet | Kim, Kyekyoon Kevin Pack, Daniel W. |
author_sort | Kim, Kyekyoon Kevin |
collection | PubMed |
description | With advances in biotechnology, genomics, and combinatorial chemistry, a wide variety of new, more potent and specific therapeutics are being created. Because of common problems such as low solubility, high potency, and/or poor stability of many of these new drugs, the means of drug delivery can impact efficacy and potential for commercialization as much as the nature of the drug itself. Thus, there is a corresponding need for safer and more effective methods and devices for drug delivery. Indeed, drug delivery systems—designed to provide a therapeutic agent in the needed amount, at the right time, to the proper location in the body, in a manner that optimizes efficacy, increases compliance and minimizes side effects—were responsible for $47 billion in sales in 2002, and the drug delivery market is expected to grow to $67 billion by 2006. |
format | Online Article Text |
id | pubmed-7122341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71223412020-04-06 Microspheres for Drug Delivery Kim, Kyekyoon Kevin Pack, Daniel W. BioMEMS and Biomedical Nanotechnology Article With advances in biotechnology, genomics, and combinatorial chemistry, a wide variety of new, more potent and specific therapeutics are being created. Because of common problems such as low solubility, high potency, and/or poor stability of many of these new drugs, the means of drug delivery can impact efficacy and potential for commercialization as much as the nature of the drug itself. Thus, there is a corresponding need for safer and more effective methods and devices for drug delivery. Indeed, drug delivery systems—designed to provide a therapeutic agent in the needed amount, at the right time, to the proper location in the body, in a manner that optimizes efficacy, increases compliance and minimizes side effects—were responsible for $47 billion in sales in 2002, and the drug delivery market is expected to grow to $67 billion by 2006. 2006 /pmc/articles/PMC7122341/ http://dx.doi.org/10.1007/978-0-387-25842-3_2 Text en © Springer Science + Business Media, LLC 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Kim, Kyekyoon Kevin Pack, Daniel W. Microspheres for Drug Delivery |
title | Microspheres for Drug Delivery |
title_full | Microspheres for Drug Delivery |
title_fullStr | Microspheres for Drug Delivery |
title_full_unstemmed | Microspheres for Drug Delivery |
title_short | Microspheres for Drug Delivery |
title_sort | microspheres for drug delivery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122341/ http://dx.doi.org/10.1007/978-0-387-25842-3_2 |
work_keys_str_mv | AT kimkyekyoonkevin microspheresfordrugdelivery AT packdanielw microspheresfordrugdelivery |